Evidence map›Paper›PMID 25420746›Full record

ArticleBMC bioinformatics2014

A simple peak detection and label-free quantitation algorithm for chromatography-mass spectrometry.

Ken Aoshima, Kentaro Takahashi, Masayuki Ikawa, Takayuki Kimura, Mitsuru Fukuda, Satoshi Tanaka, Howell E Parry, Yuichiro Fujita, Akiyasu C Yoshizawa, Shin-Ichi Utsunomiya and 3 more

Abstract read
In one paragraph

Article in BMC bioinformatics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Probing HMolecular & cellular proteomics : MCP · 2019
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ken AoshimaEisai Co., Ltd., Tsukuba, Ibaraki, 300-2635, Japan. k3-aoshima@hhc.eisai.co.jp.
Kentaro TakahashiEisai Co., Ltd., Tsukuba, Ibaraki, 300-2635, Japan. k20-takahashi@hhc.eisai.co.jp.
Masayuki IkawaiBio Tech Co., Ltd., Tsukuba, Ibaraki, 305-0031, Japan. m_ikawa@ibio-tech.com.
Takayuki KimuraEisai Co., Ltd., Tsukuba, Ibaraki, 300-2635, Japan. t4-kimura@hhc.eisai.co.jp.
Mitsuru FukudaiBio Tech Co., Ltd., Tsukuba, Ibaraki, 305-0031, Japan. m_fukuda@ibio-tech.com.
Satoshi TanakaShimadzu Corporation, Kyoto, 604-8511, Japan. satstnka@shimadzu.co.jp.
Howell E ParryShimadzu Corporation, Kyoto, 604-8511, Japan. howell.parry@thermofisher.com.
Yuichiro FujitaShimadzu Corporation, Kyoto, 604-8511, Japan. yfujita@shimadzu.co.jp.
Akiyasu C YoshizawaShimadzu Corporation, Kyoto, 604-8511, Japan. acyshzw@shimadzu.co.jp.
Shin-Ichi UtsunomiyaShimadzu Corporation, Kyoto, 604-8511, Japan. utu@shimadzu.co.jp.
Shigeki KajiharaShimadzu Corporation, Kyoto, 604-8511, Japan. kajihara@shimadzu.co.jp.
Koichi TanakaShimadzu Corporation, Kyoto, 604-8511, Japan. koichi-t@shimadzu.co.jp.
Yoshiya OdaEisai Co., Ltd., Tsukuba, Ibaraki, 300-2635, Japan. y-oda@hhc.eisai.co.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLabel-free quantitation of mass spectrometric data is one of the simplest and least expensive methods for differential expression profiling of proteins and metabolites. The need for high accuracy and performance computational label-free quantitation methods is still high in the biomarker and drug discovery research field. However, recent most advanced types of LC-MS generate huge amounts of analytical data with high scan speed, high accuracy and resolution, which is often impossible to interpret manually. Moreover, there are still issues to be improved for recent label-free methods, such as how to reduce false positive/negatives of the candidate peaks, how to expand scalability and how to enhance and automate data processing. AB3D (A simple label-free quantitation algorithm for Biomarker Discovery in Diagnostics and Drug discovery using LC-MS) has addressed these issues and has the capability to perform label-free quantitation using MS1 for proteomics study.

resultsWe developed an algorithm called AB3D, a label free peak detection and quantitative algorithm using MS1 spectral data. To test our algorithm, practical applications of AB3D for LC-MS data sets were evaluated using 3 datasets. Comparisons were then carried out between widely used software tools such as MZmine 2, MSight, SuperHirn, OpenMS and our algorithm AB3D, using the same LC-MS datasets. All quantitative results were confirmed manually, and we found that AB3D could properly identify and quantify known peptides with fewer false positives and false negatives compared to four other existing software tools using either the standard peptide mixture or the real complex biological samples of Bartonella quintana (strain JK31). Moreover, AB3D showed the best reliability by comparing the variability between two technical replicates using a complex peptide mixture of HeLa and BSA samples. For performance, the AB3D algorithm is about 1.2 - 15 times faster than the four other existing software tools.

conclusionsAB3D is a simple and fast algorithm for label-free quantitation using MS1 mass spectrometry data for large scale LC-MS data analysis with higher true positive and reasonable false positive rates. Furthermore, AB3D demonstrated the best reproducibility and is about 1.2- 15 times faster than those of existing 4 software tools.

Indexed as

AlgorithmsDatabases, ProteinSoftwareAnimalsCattleChromatography, LiquidHeLa CellsHumansMass SpectrometryPeptide FragmentsProteinsProteomeProteomicsSerum Albumin, BovinePeptide FragmentsProteinsProteomeSerum Albumin, Bovine

Identifiers

PMID25420746
PMCPMC4252003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.